The treatment with L-dopa and amantadine in Parkinson's disease.

作者信息

Pendefunda G, Pollingher B, Stefanache F, Gavril A, Oprisan C, Merling M, Nemteanu E, Ciunru M, Koropitzer I

出版信息

Ther Hung. 1975;23(1):12-6.

PMID:1105871

Abstract

摘要

相似文献

The treatment with L-dopa and amantadine in Parkinson's disease.

Ther Hung. 1975;23(1):12-6.

[Comparative study on Parkopan, Amantadine and L-dopa in the treatment of Parkinson's disease].

Med Arh. 1974 Jul-Aug;28(4):407-15.

L-dopa and amantadine hydrochloride in Parkinson's disease.

Int Z Klin Pharmakol Ther Toxikol. 1971 Apr;4(3):356-60.

Amantadine and a fixed combination of carbidopa and levodopa in parkinsonism: a preliminary report.

Curr Ther Res Clin Exp. 1976 Mar;19(3):337-8.

[Results of two new drugs in Parkinson's disease: L-dopa and amantadine].

Rev Neurol (Paris). 1970 Feb;122(2):145-8.

Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease.

Trans Am Neurol Assoc. 1969;94:85-90.

Clinical and electromyographic examinations on the effect of hydrochloride (Viregyt-K) in the treatment of Parkinson's disease.

Ther Hung. 1977;25(2):55-63.

The L-dopa sparing effect of G 31,406 in the treatment of parkinson's disease.

Neurol Neurocir Psiquiatr. 1976;17(4):285-92.

[Secondary effects of prolonged levodopa therapy in Parkinson's disease].

Med Clin (Barc). 1985 Jun 15;85(3):88-91.

Is pathological gambling in Parkinson's disease reduced by amantadine?

Ann Neurol. 2011 Jan;69(1):213-4; author reply 214-5. doi: 10.1002/ana.22289.

引用本文的文献

Parkinson's Disease in Romania: A Scoping Review.

Brain Sci. 2021 May 27;11(6):709. doi: 10.3390/brainsci11060709.

Amantadine in Parkinson's disease.

Cochrane Database Syst Rev. 2003;2003(1):CD003468. doi: 10.1002/14651858.CD003468.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验